Johannes Fruehauf, BioLabs | Reinventing Incubators For The Success of Biotech Startups | E05
Listen now
Description
We’re back live and in Paris with our next guest, Johannes Fruehauf. We talk about reinventing the co-working labs for biotech startups, the difficulties of doing business in Europe, profitability in biotech, and much more (see timestamps below). 💎 ABOUT THE SPEAKER Johannes is the President, CEO, and founder of BioLabs, the biggest “incubator”, or as they like to call it “co-working laboratory”, platform for biotech startups in the world. Today they have over 14 locations, including 3 in Europe (2 in Paris and 1 in Heidelberg). He is also the founder of LabCentral and a general partner at Mission BioCapital.  ⏰ TIMESTAMPS [00:00:00] Intro [00:00:39] Welcome to this new episode [00:02:19] How & why reinvent biotech incubators [00:14:14] The competitors [00:17:41] Entrepreneurship in Europe [00:22:11] The Challenges of doing business in Europe [00:29:37] People make it happen [00:36:51] BioLabs in Asia and Japan [00:41:46] Is a higher risk tolerance a good thing for everyone? [00:48:22] Money: being profitable in life sciences and not raising money if you don't have to. [00:59:15] Synergies between real estate and investing [01:14:01] Should you get a business coach? [01:25:52] Thanks for listening 📜 TRANSCRIPT Read the full transcript here: https://tinyurl.com/mt9dva8u 🔗 FOLLOW US - Don't miss an episode by signing up for our monthly newsletter: http://eepurl.com/h_fnmH - LinkedIn: https://www.linkedin.com/company/flot-bio/ - Twitter: https://twitter.com/FlotBio 🎙️ ABOUT FLOT.BIO Our show is a unique addition to the European podcast scene, complementing other news-focused or locally-targeted podcasts. We bring you rare long-form conversations with the best in European biotech. Your host Philip animates the conversation to dig out exciting, and sometimes contrarian ideas. Those might inspire you and help you grow. 10k monthly views. ⭐️ SPONSORSHIP Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts! 🙏 LIKE/FOLLOW/REVIEW Did you enjoy the episode? Let us know your thoughts and what you found useful by dropping a comment. Also, make sure you like the episode and follow our channel so you never miss an episode and help others find it too.
More Episodes
We’re online with Adrian Rawcliffe, the CEO of Adaptimmune, the TCR cell therapy company behind the first engineered cell therapy for solid tumors that was approved for a rare form of sarcoma. We talked about Tecelra's commercial rollout. We also talked about what's next in cell therapy, and...
Published 10/28/24
Published 10/28/24